Cukier 1985.

Methods	Multisite study Randomization: numbered or coded identical containers administered sequentially Blinding: participants, providers
Participants	Geographic region: France Study setting: community N = 168 Baseline IPSS: NR Baseline prostate volume: NR Mean age (range): 69 (NR) years Race: white Diagnostic criteria: patients with "prostatism" or for whom surgery was not indicated (no mechanical or infectious complications)
Interventions	Control: matching placebo Treatment: Permixon 160 mg twice daily Study duration: 10 weeks Lost to follow‐up: 13%
Outcomes	Symptom score (# of daily mictions) Dysuria (4‐point scale) Bladder residual volume Nocturia Dropouts due to side effects: NR
Notes	Exclusions: symptoms for at least 6 months Full text not available for this update.